DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

LinksSchließen

Referenz

Weitz JI, Bauersachs R, Beyer-Westendorf J. et al; EINSTEIN CHOICE Investigators.
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study.

Thromb Haemost 2015;
114 (03) 645-650

Bibliographische Angaben herunterladen

Aufrufen in: